维普期刊资源整合服务平台（V6.5）

170篇 您的检索式：作者名="STADLER W"

选中清除导出查看参考文献查看引证文献引用追踪共9页首页上一页第1页下一页末页 /9 跳转

	题名	作者	年代	出处	被引量
1	Phase Ⅱ trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck显示文摘	Cohen E E Rosen F Stadler W M	2003	J Clin Oncol2003，21，10：	1
2	Sorafenib,therapeutic modalities显示文摘	Hahn O Stadler W	2006	Curr Opin Oncol2006，18，6：	1
3	Business cycle models with endogenous technology显示文摘	Stadler G W	1990	American Economic Review1990，80，4：	1
4	Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site显示文摘	KAUFFMAN E C ROBINSON V L STADLER W M	2003	J Urol2003，169，：	1
5	Increased p16 levels correlate with pRb alterations in human urothelial cells显示文摘	Yeager T stadler W Belair C	1995	Cancer Res1995，55，：	1
6	Phase Ⅱ trial of ZD1839 in re- current or metastatic squamous cell carcinoma of the head and neck 显示文摘	Cohen E E Rosen F Stadler W M	2003	J Clin Oncol2003，21，10：	1
7	The role of systemic chem- otherapy in the treatment o{ kidney cancer显示文摘	George C M Stadler W M	2003	Cancer Treat Res2003，116，：	1
8	Increased p16 levels correlate with pRb alterations in buman urothelial cells显示文摘	Yeager T Stadler W Belair C	1995	Cancer Res1995，55，：	1
9	Metastasis Suppression:the Evolving Role of Metastasis Suppressor Genes for Regulating Cancer Cell Growth at the Secondary Site显示文摘	Kauffman E C Robinson V L Stadler W M	2003	J Urol2003，169，3：	1
10	Randomized Phase Ⅱ study of multiple does levels of CCI -779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinomas显示文摘	ATKINS M B HIDALGO M STADLER W M	2004	J Clin Oncol2004，22，：	1
11	Modeling of H+ and Cu2+ adsorption on calcium montmorillonite显示文摘	Stadler M Schindler P W		0，，3：	1
12	Chemical and isotopic indicators of point-source recharge to a karst aquifer,South Australia显示文摘	Herczeg A L Leaney F W J Stadler M F	1997	Journal of Hydrology1997，192，14：	1
13	Randomized phase Ⅱ study of multiple dose levels of CCI - 779, a novel mammalian target of rapamycin kinase inhibitor, in patients with ad- vanced refractory renal cell carcinoma显示文摘	ATKINS M B HIDALGO M STADLER W M	2004	J Clin Oncol2004，22，5：	1
14	A randomized phase Ⅱ trial of the matrix metalloproteinase inhibitor BMS-275291 in hormone-refractory prostate cancer patients with bone metastases显示文摘	LARA P N STADLER W M LONGMATE J	2006	Clin Cancer Res2006，12，5：	1
15	A phase II study of gemcitabine and capecitabine in metastatic renal cancer: a report of Cancer and Leukemia Group B pro- tocolg0008显示文摘	Stadler W M Halabi S Rini B	2006	Cancer2006，107，6：	1
16	Phase Ⅱ study of the efficacy and safety of oral GD0039 in patients with locally advanced or metastatic renal cell carcinoma 显示文摘	Shaheen P E Stadler W Elson P	2005	Investigational New Drugs2005，23，：	1
17	Influence of bacterial exopolymers on cell adhesion of desulfo- vibrio vulgaris on high alloyed steel: corrosion inhibi- tion by extracellular polymeric substances (EPS)显示文摘	STADLER R WEI L FURBETH W	2010	Materials Corrosion2010，61，12：	1
18	Modeling of H^+ and Cu^2+ adsorption on calcium montmorillonite 显示文摘	Stadler M Schindler P W	1993	Clays and Clay Mineral1993，41，3：	1
19	Urinary nuclear matrix proteinas a marker for transitional cell carcinoma of the urinary tract显示文摘	Carpinito G A Stadler W M Briggman J V	1996	J Urol1996，156，4：	1
20	First e- valuation of the applicability of microbial extracellular polymeric substances for corrosion protection of metal substrates显示文摘	STADLER R FUERBETH W HARNEI T	2008	Electrochim Acta2008，，54：	1

返回顶部每页显示：

共9页首页上一页第1页下一页末页 /9 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示